Maolin Ge
Impact in
-
- MicroRNA in disease regulation
Papers in
-
- Protein Degradation and Inhibitors 3
- CRISPR and Genetic Engineering 3
- Ubiquitin and proteasome pathways 2
- Histone Deacetylase Inhibitors Research 2
- Extracellular vesicles in disease 2
-
- interferon and immune responses 2
- Co-authors
- Han Liu (9 shared papers)Zhi Qiao (5 shared papers)Thales Papagiannakopoulos (1 shared paper)Liron Bar‐Peled (2 shared papers)Fang Liu (3 shared papers)Jianguo Wu (3 shared papers)Yan Kong (3 shared papers)Hui Lü (3 shared papers)
- Journals
- Cancer Science (2 papers)British Journal of Cancer (1 paper)FEBS Letters (1 paper)Molecular & Cellular Proteomics (1 paper)Theranostics (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Maolin Ge
18 papers receiving 239 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 49
- Immunology 45
- Molecular Biology 146
- Immunology and Allergy 10
- Hematology 15
Countries citing papers authored by Maolin Ge
This map shows the geographic impact of Maolin Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maolin Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maolin Ge more than expected).
Fields of papers citing papers by Maolin Ge
This network shows the impact of papers produced by Maolin Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maolin Ge. The network helps show where Maolin Ge may publish in the future.
Co-authors
The 25 scholars most cited alongside Maolin Ge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 41 | |
| 2 | 2017 | 31 | |
| 3 | 2015 | 27 | |
| 4 | 2023 | 25 | |
| 5 | 2017 | 20 | |
| 6 | 2011 | 17 | |
| 7 | 2020 | 17 | |
| 8 | 2020 | 16 | |
| 9 | 2019 | 11 | |
| 10 | 2022 | 8 | |
| 11 | 2020 | 7 | |
| 12 | 2020 | 5 | |
| 13 | 2014 | 4 | |
| 14 | 2013 | 4 | |
| 15 | 2020 | 3 | |
| 16 | 2025 | 2 | |
| 17 | 2019 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2025 | 0 |
About Maolin Ge
Maolin Ge is a scholar working on Molecular Biology, Immunology, Cancer Research, Genetics and Surgery, having authored 19 papers that have together received 240 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Protein Degradation and Inhibitors (3 papers), CRISPR and Genetic Engineering (3 papers), Ubiquitin and proteasome pathways (2 papers), Xenotransplantation and immune response (2 papers), interferon and immune responses (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Cancer Research (49 citations), Immunology (45 citations), Molecular Biology (146 citations), Immunology and Allergy (10 citations) and Hematology (15 citations). Maolin Ge has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Han Liu, Zhi Qiao, Thales Papagiannakopoulos, Liron Bar‐Peled, Fang Liu, Jianguo Wu, Yan Kong, Hui Lü, Zhen Luo and Hua Xiao. Their work appears in journals such as Cancer Science, British Journal of Cancer, FEBS Letters, Molecular & Cellular Proteomics and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.